Wyeth Premarin/Prempro Cardioprotection Claim On Hold Until 2005

Wyeth-Ayerst's pursuit of a cardioprotection claim for conjugated estrogens is likely delayed until 2005-2007 following the negative outcome of the Heart and Estrogen/Progestin Replacement Study.

More from Archive

More from Pink Sheet